What you need to know
The analgesics market has experienced modest growth in recent years, rising 11% between 2011 and 2016, with similar growth trends expected through 2021. The majority of consumers turn to some form of OTC (over-the-counter) analgesic to treat pain, with internal analgesics remaining the dominate choice for pain relief, though external analgesics continue to experience faster growth. Looking forward, consumers’ need for pain treatments is not expected to change, and a preference for familiar brands will remain; however, interest is growing for natural ingredients and easy-to-use formats.
Definition
For the purposes of this Report, Mintel has segmented the analgesics market as follows:
OTC internal analgesics
Acetaminophen, aspirin, ibuprofen, naproxen sodium, magnesium salicylate
OTC external analgesics
Rubs – such as topical creams/sprays and patches/wraps – with heating/cooling properties
Excluded from this Report are:
Antihistamines, decongestants, sinus, cough, cold, and flu remedies
In addition, this Report focuses on the analgesics products marketed for pain relief that are available over the counter/without a prescription. Other products that provide pain relief but are not included in the market size of this Report, but may be mentioned in the Report, are muscle/body support devices and electrotherapy devices.
